ReviewFrontiers in pharmacology2023

Efficacy and safety of hypoxia-inducible factor-prolyl hydroxylase inhibitor treatment for anemia in chronic kidney disease: an umbrella review of meta-analyses.

Song Ren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.